These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24987862)

  • 41. Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy.
    Haser GC; Sumpio B
    J Vasc Surg; 2017 Mar; 65(3):849-859. PubMed ID: 26994951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterations.
    Teer E; Joseph DE; Driescher N; Nell TA; Dominick L; Midgley N; Deshpande G; Page MJ; Pretorius E; Woudberg NJ; Lecour S; Glashoff RH; Essop MF
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1146-H1157. PubMed ID: 30768357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dyslipidemia in Human Immunodeficiency Virus Disease: JACC Review Topic of the Week.
    Kalra DK; Vorla M; Michos ED; Agarwala A; Virani S; Duell PB; Raal FJ
    J Am Coll Cardiol; 2023 Jul; 82(2):171-181. PubMed ID: 37407116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients.
    Banach M; Dinca M; Ursoniu S; Serban MC; Howard G; Mikhailidis DP; Nicholls S; Lip GYH; Glasser S; Martin SS; Muntner P; Rysz J; Toth PP; Sahebkar A;
    Pharmacol Res; 2016 Sep; 111():343-356. PubMed ID: 27350264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.
    Llibre JM; Domingo P; Palacios R; Santos J; Pérez-Elías MJ; Sánchez-de la Rosa R; Miralles C; Antela A; Moreno S;
    AIDS; 2006 Jun; 20(10):1407-14. PubMed ID: 16791015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Post-prandial lipid effects of raltegravir versus darunavir/ritonavir in HIV-1-infected adults commencing combination ART.
    Lee FJ; Marriott D; Bloch M; Richardson R; Mackenzie N; Carr A
    J Antimicrob Chemother; 2016 Apr; 71(4):1127-9. PubMed ID: 26682962
    [No Abstract]   [Full Text] [Related]  

  • 47. High molecular weight form of adiponectin in antiretroviral drug-induced dyslipidemia in HIV-infected Japanese individuals based on in vivo and in vitro analyses.
    Minami R; Yamamoto M; Takahama S; Ando H; Miyamura T; Suematsu E
    Intern Med; 2009; 48(20):1799-875. PubMed ID: 19834271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LIPID abnormalities in patients infected with human immunodeficiency virus.
    Mikhail NE
    Endocr Pract; 2008; 14(4):492-500. PubMed ID: 18558606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
    Hiransuthikul N; Hiransuthikul P; Kanasook Y
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence.
    Willig AL; Overton ET
    Curr HIV/AIDS Rep; 2016 Oct; 13(5):289-96. PubMed ID: 27541600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular complications in HIV management: past, present, and future.
    Aberg JA
    J Acquir Immune Defic Syndr; 2009 Jan; 50(1):54-64. PubMed ID: 19295335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.
    Arnedo M; Taffé P; Sahli R; Furrer H; Hirschel B; Elzi L; Weber R; Vernazza P; Bernasconi E; Darioli R; Bergmann S; Beckmann JS; Telenti A; Tarr PE;
    Pharmacogenet Genomics; 2007 Sep; 17(9):755-64. PubMed ID: 17700364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study.
    Abebe M; Kinde S; Belay G; Gebreegziabxier A; Challa F; Gebeyehu T; Nigussie P; Tegbaru B
    BMC Res Notes; 2014 Jun; 7():380. PubMed ID: 24950924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.
    Ahmed MH; Al-Atta A; Hamad MA
    Expert Opin Pharmacother; 2012 Sep; 13(13):1901-9. PubMed ID: 22770622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medications not intended for treatment of dyslipidemias and with a variable effect on lipids.
    Whayne TF; Mukherjee D
    Curr Pharm Des; 2014; 20(40):6325-38. PubMed ID: 24953390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV and its relationship to insulin resistance and lipid abnormalities.
    Non LR; Escota GV; Powderly WG
    Transl Res; 2017 May; 183():41-56. PubMed ID: 28068521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of lipodystrophy and dyslipidemia among patients with HIV infection on generic ART in rural South India.
    Kalyanasundaram AP; Jacob SM; Hemalatha R; Sivakumar MR
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(5):329-34. PubMed ID: 21508297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short communication: Lipids and cardiovascular risk after switching HIV-1 patients on nevirapine and emtricitabine/tenofovir-DF to rilpivirine/emtricitabine/tenofovir-DF.
    Rokx C; Verbon A; Rijnders BJ
    AIDS Res Hum Retroviruses; 2015 Apr; 31(4):363-7. PubMed ID: 25625211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating metabolomic profile can predict dyslipidemia in HIV patients undergoing antiretroviral therapy.
    Rodríguez-Gallego E; Gómez J; Domingo P; Ferrando-Martínez S; Peraire J; Viladés C; Veloso S; López-Dupla M; Beltrán-Debón R; Alba V; Vargas M; Castellano AJ; Leal M; Pacheco YM; Ruiz-Mateos E; Gutiérrez F; Vidal F; Rull A;
    Atherosclerosis; 2018 Jun; 273():28-36. PubMed ID: 29677628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nutritional and metabolic correlates of cardiovascular and bone disease in HIV-infected patients.
    Fitch K; Grinspoon S
    Am J Clin Nutr; 2011 Dec; 94(6):1721S-1728S. PubMed ID: 22089442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.